Human papillomavirus (HPV): College male's knowledge, perceived risk, sources of information, vaccine barriers and communication

Journal of Men's Health

Volumn 8, Issue 3, 2011, Pages 175-184

  Katz, Mira L ^a   Krieger, Janice L ^a,b   Roberto, Anthony J ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

HPV vaccine; Human papillomavirus; Males; Sexually transmitted infection

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ADVERTIZING; ARTICLE; COLLEGE STUDENT; COMMERCIAL PHENOMENA; DRUG COST; DRUG EFFECT; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; INTERPERSONAL COMMUNICATION; KNOWLEDGE; MALE; MASS MEDIUM; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEN'S HEALTH; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; SEXUAL INTERCOURSE; VACCINATION; WART VIRUS;

EID: 80052866900     PISSN: 18756867     EISSN: 18756859     Source Type: Journal    
DOI: 10.1016/j.jomh.2011.04.002     Document Type: Article

References (32)

1. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. J Am Med Assoc 2007, 297:813-819.
2. Weinstock H., Berman S., Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004, 36:6-10.
3. Dinh T.H., Sternberg M., Dunne E.F., Markowitz L.E. Genital warts among 18- to 59-year-olds in the United States, National Health and Nutrition Examination Survey, 1999-2004. Sex Transm Dis 2008, 35:357-360.
4. Munoz N., Castellsague X., de Gonzalez A.B., Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006, 24(Suppl 3). S3/1-10.
5. Nielson C.M., Flores R., Harris R.B., Abrahamsen M., Papenfuss M.R., Dunne E.F., et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev 2007, 16:1107-1114.
6. Palefsky J.M. Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health 2010, 46(4 Suppl):S12-S19.
7. Parkin D.M., Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006, 24(Suppl 3). S3/11-25.
8. Gillison M.L., Chaturvedi A.K., Lowy D.R. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008, 113:3036-3046.
9. American College Health Association American College Health Association - National College Health Assessment II, Reference Group Executive Summary, Spring 2010 2010, American College Health Association, Linthicum, MD.
10. Siegel D.M., Klein D.I., Roghmann K.J. Sexual behavior, contraception, and risk among college students. J Adolesc Health 1999, 25:336-343.
11. United States Food and Drug Administration. FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus. FDA News Release, June 8, 2006, Silver Spring, MD. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108666.htm.
12. United States Food and Drug Administration. FDA Approves Expanded Use for Garasil to Include Preventing Certain Vulvar and Vaginal Cancers. FDA News Release, September 12, 2008, Silver Spring, MD. Available at: http://www.fda.gov/newsevents/newsroom/pressannouncements/2008/ucm116945.htm.
13. Centers for Disease Control Prevention (CDC) FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 2010, 59(20):630-632.
14. United States Food and Drug Administration. FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys. FDA News Release, October 16, 2009, Silver Spring, MD. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187003.htm.
15. United States Food and Drug Administration. Gardasil Approved to Prevent Anal Cancer. FDA News Release, December 22, 2010, Silver Spring, MD. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm237941.htm.
16. Daley E.M., Marhefka S.L., Buhi E.R., Vamos C.A., Hernandez N.D., Giuliano A.R. Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample. Sex Transm Dis 2010, 37:644-652.
17. Hernandez B.Y., Wilkens L.R., Thompson P.J., Shvetsov Y.B., Goodman M.T., Ning L., et al. Acceptability of prophylactic human papillomavirus vaccination among adult men. Hum Vaccin 2010, 6:467-475.
18. Liddon N., Hood J., Wynn B.A., Markowitz L.E. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health 2010, 46:113-123.
19. Reiter P.L., Brewer N.T., Smith J.S. Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sex Transm Infect 2010, 86:241-246.
20. Witte K., Cameron K.A., McKeon J.K., Berkowitz J.M. Predicting risk behaviors: development and validation of a diagnostic scale. J Health Commun 1996, 1:317-341.
21. Brewer N.T., Ng T.W., McRee A.L., Reiter P.L. Men's beliefs about HPV-related disease. J Behav Med 2010, 33:274-281.
22. Ferris D.G., Waller J.L., Miller J., Patel P., Price G.A., Jackson L., et al. Variables associated with human papillomavirus (HPV) vaccine acceptance by men. J Am Board Fam Med 2009, 22:34-42.
23. Gerend M.A., Barley J. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis 2009, 36:58-62.
24. Jones M., Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health 2008, 57:23-32.
25. Reiter P.L., Brewer N.T., McRee A.L., Gilbert P., Smith J.S. Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sex Transm Dis 2010, 37:197-203.
26. Sandfort J.R., Pleasant A. Knowledge, attitudes, and informational behaviors of college students in regard to the human papillomavirus. J Am Coll Health 2009, 58:141-149.
27. Allen J.D., Fantasia H.C., Fontenot H., Flaherty S., Santana J. College men's knowledge, attitudes, and beliefs about the human papillomavirus infection and vaccine. J Adolesc Health 2009, 45:535-537.
28. Robert A.C., Sonenstein F.L. Adolescents' reports of communication with their parents about sexually transmitted diseases and birth control: 1988, 1995, and 2002. J Adolesc Health 2010, 46:532-537.
29. Aspy C.B., Vesely S.K., Oman R.F., Rodine S., Marshall L., McLeroy K. Parental communication and youth sexual behaviour. J Adolesc 2007, 30:449-466.
30. Miller K.S., Levin M.L., Whitaker D.J., Xu X. Patterns of condom use among adolescents: the impact of mother-adolescent communication. Am J Public Health 1998, 88:1542-1544.
31. Cardarelli R., Cardarelli K.M. Recommendations for primary care physicians to improve HPV vaccination rates during clinical encounters. Osteopath Med Prim Care 2008, 2:10.
32. McRee A.L., Reiter P.L., Chantala K., Brewer N.T. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?. Cancer Epidemiol Biomarkers Prev 2010, 19:1937-1944.